EMEA-002287-PIP01-17-M03
Key facts
| Active substance |
Cotadutide
|
| Therapeutic area |
Endocrinology, -gynacology-fertility-metabolism
|
| Decision number |
P/0506/2021
|
| PIP number |
EMEA-002287-PIP01-17-M03
|
| Pharmaceutical form(s) |
Solution for injection
|
| Condition(s) / indication(s) |
Treatment of type II diabetes mellitus
|
| Route(s) of administration |
Subcutaneous use
|
| Contact for public enquiries |
AstraZeneca AB
Email: paediatrics@astrazeneca.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|